Combined hormonal contraceptives in BRCA gene mutation carriers: why not?

Eur J Contracept Reprod Health Care. 2019 Dec;24(6):417-419. doi: 10.1080/13625187.2019.1647335. Epub 2019 Jul 30.
No abstract available

MeSH terms

  • Breast Neoplasms / genetics
  • Contraceptive Agents, Hormonal / adverse effects
  • Contraceptive Agents, Hormonal / therapeutic use*
  • Female
  • Genes, BRCA1*
  • Genes, BRCA2*
  • Genetic Predisposition to Disease / genetics
  • Heterozygote*
  • Humans
  • Mutation / genetics

Substances

  • Contraceptive Agents, Hormonal